Dolby Laboratories (DLB): Price and Financial Metrics
Dolby Laboratories (DLB)
Today's Latest Price: $71.72 USD
Updated Oct 23 7:00pm
Add DLB to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 38 in Technology - Electronics
See all "A" rated Strong Buy stocks
DLB Stock Summary
- For DLB, its debt to operating expenses ratio is greater than that reported by merely 11.55% of US equities we're observing.
- DLB's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of merely 13.36% of US stocks.
- The volatility of Dolby Laboratories Inc's share price is greater than that of only 7.32% US stocks with at least 200 days of trading history.
- Stocks that are quantitatively similar to DLB, based on their financial statements, market capitalization, and price volatility, are VRNT, NTGR, YY, AEHR, and FFIV.
- DLB's SEC filings can be seen here. And to visit Dolby Laboratories Inc's official web site, go to www.dolby.com.
DLB Stock Price Chart Interactive Chart >
DLB Price/Volume Stats
| Current price | $71.72 | 52-week high | $73.94 |
| Prev. close | $71.00 | 52-week low | $44.68 |
| Day low | $70.71 | Volume | 285,176 |
| Day high | $71.91 | Avg. volume | 442,810 |
| 50-day MA | $67.81 | Dividend yield | 1.23% |
| 200-day MA | $64.58 | Market Cap | 7.21B |
Dolby Laboratories (DLB) Company Bio
Dolby Laboratories creates audio, imaging, and communication technologies that transform entertainment and communications at the cinema, at home, at work, and on mobile devices. The company was founded in 1965 and is based in San Francisco, California.
DLB Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $71.72 | $35.9 | -49% |
Below please find a table outlining a discounted cash flow forecast for DLB, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Dolby Laboratories Inc ranked in the 31th percentile in terms of potential gain offered. We should note, though, that the most conservative analysis suggests this stock will yield negative results -- and thus may be a potential short opportunity. In terms of the factors that were most noteworthy in this DCF analysis for DLB, they are:
- The business' balance sheet reveals debt to be 1% of the company's capital (with equity being the remaining amount). Approximately merely 5.76% of US stocks with free cash flow have a lower reliance on debt in their capital structure.
- DLB's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 2%; for context, that number is higher than 55.02% of tickers in our DCF set.
- As a business, Dolby Laboratories Inc experienced a tax rate of about 5% over the past twelve months; relative to its sector (Consumer Cyclical), this tax rate is higher than merely 23.13% of stocks generating free cash flow.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | -50% |
| 1% | -49% |
| 2% | -49% |
| 3% | -48% |
| 4% | -48% |
| 5% | -47% |
JOUT, ATR, MNRO, IGT, and AAP can be thought of as valuation peers to DLB, in the sense that they are in the Consumer Cyclical sector and have a similar price forecast based on DCF valuation.
Loading social stream, please wait...